Altinoz, M. A. Et Al. 2021. PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease. MOLECULAR ASPECTS OF MEDICINE , vol.78 .

Altinoz, M. A., Elmacı, I., Hacımüftüoğlu, A., Ozpinar, A., Hacker, E., & Özpınar, A., (2021). PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease. MOLECULAR ASPECTS OF MEDICINE , vol.78.

Altinoz, Meric Et Al. "PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease," MOLECULAR ASPECTS OF MEDICINE , vol.78, 2021

Altinoz, Meric A. Et Al. "PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease." MOLECULAR ASPECTS OF MEDICINE , vol.78, 2021

Altinoz, M. A. Et Al. (2021) . "PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease." MOLECULAR ASPECTS OF MEDICINE , vol.78.

@article{article, author={Meric A. Altinoz Et Al. }, title={PPAR? and its ligand erucic acid may act anti-tumoral, neuroprotective, and myelin protective in neuroblastoma, glioblastoma, and Parkinson?s disease}, journal={MOLECULAR ASPECTS OF MEDICINE}, year=2021}